Prevalence, Management of Placenta Previa, and Pregnancy Outcomes
An Update Systematic Review
Keywords:
placenta previa, maternal deaths, postpartum hemorrhageAbstract
Background:Placenta previa increases the risk of postpartum hemorrhage, leading to maternal deaths. Risk factors include advanced maternal age, multiparity, smoking, and cesarean section. Traditional treatments include hemostatic balloons, surgical sutures, and uterine artery embolization. Methods: Using PRISMA 2020 criteria, this systematic review focused on full-text English literature published between 2014 and 2024. Without a DOI, editorials and review pieces published in the same publication as the submission were rejected. The literature was compiled using various internet databases, including PubMed, ScienceDirect, and SagePub. Result: Following a thorough three-level screening process, seven publications were identified as being closely related to our current comprehensive study. Following that, the entire content was thoroughly reviewed, and these articles were subjected to extra scrutiny. Conclusion: The Society of Obstetrics and Gynecology recommends interventional treatment for placenta previa patients at high risk of hemorrhage, including balloon occlusion, to reduce bleeding, shorten operation time, and reduce postoperative complications.References
Anderson-Bagga FM, Sze A. Placenta Previa. [Updated 2023 Jun 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539818/
Ryu, J. M., Choi, Y. S., & Bae, J. Y. (2019). Bleeding control using intrauterine continuous running suture during cesarean section in pregnant women with placenta previa. Archives of Gynecology and Obstetrics, 299(1), 135–139. https://doi.org/10.1007/s00404-018-4957-4
Abbas, A. M., Shady, N. W., & Sallam, H. F. (2019). Bilateral uterine artery ligation plus intravenous tranexamic acid during cesarean delivery for placenta previa: a randomized double-blind controlled trial. Journal of Gynecology Obstetrics and Human Reproduction, 48(2), 115–119. https://doi.org/10.1016/j.jogoh.2018.10.023
Fan, D., Xia, Q., Liu, L., Wu, S., Tian, G., Wang, W., Wu, S., Guo, X., & Liu, Z. (2017). The Incidence of Postpartum Hemorrhage in Pregnant Women with Placenta Previa: A Systematic Review and Meta-Analysis. PloS One, 12(1), e0170194. https://doi.org/10.1371/journal.pone.0170194
Verspyck, E., De Vienne, C., Muszynski, C., Bubenheim, M., Chanavaz-Lacheray, I., Dreyfus, M., Deruelle, P., & Benichou, J. (2017). Maintenance nifedipine therapy for preterm symptomatic placenta previa: A randomized, multicenter, double-blind, placebo-controlled trial. PLoS ONE, 12(3), 1–13. https://doi.org/10.1371/journal.pone.0173717
Xu, X., & Zhu, X. (2022). Combined Efficacy of Balloon Occlusion and Uterine Artery Embolization on Coagulation Function in Patients with High-Risk Placenta Previa during Cesarean Section. International Journal of Clinical Practice, 2022, 7750598. https://doi.org/10.1155/2022/7750598
Radaelli, T., Ferrari, M. M., Duiella, S. F., Gazzola, F. G., Campoleoni, M., Merlini, C., Martinetti, L., Ambrosini, M. T., Ossola, M. W., & Nicolini, A. (2022). Prophylactic intraoperative uterine artery embolization for the management of major placenta previa. Journal of Maternal-Fetal and Neonatal Medicine, 35(17), 3359–3364. https://doi.org/10.1080/14767058.2020.1818218
Alsayegh, E., Barrett, J., & Melamed, N. (2019). Optimal timing of antenatal corticosteroids in women with bleeding placenta previa or low-lying placenta *. Journal of Maternal-Fetal and Neonatal Medicine, 32(12), 1971–1977. https://doi.org/10.1080/14767058.2017.1422713
Vahanian, S. A., Lavery, J. A., Ananth, C. V, & Vintzileos, A. (2015). Placental implantation abnormalities and risk of preterm delivery: a systematic review and metaanalysis. American Journal of Obstetrics and Gynecology, 213(4 Suppl), S78-90. https://doi.org/10.1016/j.ajog.2015.05.058
Shaamash, A. H., Ali, M. K., & Attyia, K. M. (2020). Intramuscular 17α-hydroxyprogesterone caproate to decrease preterm delivery in women with placenta praevia: a randomised controlled trial. Journal of Obstetrics and Gynaecology, 40(5), 633–638. https://doi.org/10.1080/01443615.2019.1645099
Chen, H., Tan, H., Luo, P. X., Shen, Y. F., Lyu, C. C., Qian, X. W., & Chen, X. Z. (2020). Comparison of cell salvage with one and two suction devices during cesarean section in patients with placenta previa and/or accrete: a randomized controlled trial. Chinese Medical Journal, 0(6), 638–643.https://doi.org/10.1097/CM9.0000000000000699
Goucher, H., Wong, C. A., Patel, S. K., & Toledo, P. (2015). Cell salvage in obstetrics. Anesthesia and Analgesia, 121(2), 465–468. https://doi.org/10.1213/ANE.0000000000000786
Broekman, E. A., Versteeg, H., Vos, L. D., Dijksterhuis, M. G., & Papatsonis, D. N. (2015). Temporary balloon occlusion of the internal iliac arteries to prevent massive hemorrhage during cesarean delivery among patients with placenta previa. International Journal of Gynecology and Obstetrics, 128(2), 118–121. https://doi.org/10.1016/j.ijgo.2014.08.021
Leung, T. Y., Cheng, Y. K. Y., Sahota, D. S., & Yu, S. C. H. (2022). Perioperative prophylactic internal iliac artery balloon occlusion for prevention of postpartum haemorrhage in placenta praevia: a randomised controlled trial (abridged secondary publication). Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi, 28 Suppl 1(1), 23–26.https://doi.org/10.1001/jamanetworkopen.2023.49628
Tang, F., Du, S., Zhao, Y., Sun, G., Lin, Y., Li, R., & Wu, X. (2019). Clinical analysis of uterine artery embolization combined with double balloon catheter plus curettage for patients with placenta previa who underwent pregnancy termination and suffered antenatal massive hemorrhage in the 2nd trimester. Medicine, 98(47), e18098. https://doi.org/10.1097/md.0000000000018098
Prasanth, S., Mehta, P., & Rajeshwari, K. (2016). Maternal and fetal outcome of placenta previa in a tertiary care institute: a prospective two year study. Indian Journal of Obstetrics and Gynecology Research, 3(3), 274. https://doi.org/10.5958/2394-2754.2016.00061.8
US Food and Drug Administration (US-FDA). 2018. Updated statement on compounded version of hydroxyprogesterone caproate. Available from: https://www.fda.gov/drugs/guidancecomplianceregulatoryinfor- mation/pharmacycompounding/ucm402614.htm
Teare, K. M., Sullivan, I. J., & Ralph, C. J. (2015). Is cell salvaged vaginal blood loss suitable for re-infusion? International Journal of Obstetric Anesthesia, 24(2), 103–110. https://doi.org/10.1016/j.ijoa.2014.12.001
Elagamy, A., Abdelaziz, A., & Ellaithy, M. (2013). The use of cell salvage in women undergoing cesarean hysterectomy for abnormal placentation. International Journal of Obstetric Anesthesia, 22(4), 289–293. https://doi.org/10.1016/j.ijoa.2013.05.007
Izbizky, G., Meller, C., Grasso, M., Velazco, A., Peralta, O., Otaño, L., & Garcia-Monaco, R. (2015). Feasibility and safety of prophylactic uterine artery catheterization and embolization in the management of placenta accreta. Journal of Vascular and Interventional Radiology, 26(2), 162–169. https://doi.org/10.1016/j.jvir.2014.10.013
Soro, M. A. P., Denys, A., de Rham, M., & Baud, D. (2017). Short & long term adverse outcomes after arterial embolisation for the treatment of postpartum haemorrhage: a systematic review. European Radiology, 27(2), 749–762. https://doi.org/10.1007/s00330-016-4395-2
Jauniaux, E. R. M., Alfirevic, Z., Bhide, A. G., Belfort, M. A., Burton, G. J., Collins, S. L., Dornan, S., Jurkovic, D., Kayem, G., Kingdom, J., Silver, R., & Sentilhes, L. (2019). Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. BJOG: An International Journal of Obstetrics and Gynaecology, 126(1), e1–e48. https://doi.org/10.1111/1471-0528.15306
Wei, Y., Luo, J., & Luo, D. (2019). Comparison of Efficacy between Internal Iliac Artery and Abdominal Aorta Balloon Occlusions in Pernicious Placenta Previa Patients with Placenta Accrete. Gynecologic and Obstetric Investigation, 84(4), 343–349. https://doi.org/10.1159/000494493
Zhou, X., Sun, X., Wang, M., Huang, L., & Xiong, W. (2021). The effectiveness of prophylactic internal iliac artery balloon occlusion in the treatment of patients with pernicious placenta previa coexisting with placenta accreta. Journal of Maternal-Fetal and Neonatal Medicine, 34(1), 93–98. https://doi.org/10.1080/14767058.2019.1599350
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Mutia Juliana, Yahya Nurlianto (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
